@article{Mader_2023,<br/><span class="tab"></span> title={The war on hTG2: warhead optimization in small molecule human tissue transglutaminase inhibitors},<br/><span class="tab"></span> volume={14},<br/><span class="tab"></span> ISSN={2632-8682},<br/><span class="tab"></span> url={http://dx.doi.org/10.1039/d2md00378c},<br/><span class="tab"></span> DOI={10.1039/d2md00378c},<br/><span class="tab"></span> number={2},<br/><span class="tab"></span> journal={RSC Medicinal Chemistry},<br/><span class="tab"></span> publisher={Royal Society of Chemistry (RSC)},<br/><span class="tab"></span> author={Mader,<br/><span class="tab"></span> Lavleen and Watt,<br/><span class="tab"></span> Sarah K. I. and Iyer,<br/><span class="tab"></span> Harish R. and Nguyen,<br/><span class="tab"></span> Linh and Kaur,<br/><span class="tab"></span> Harpreet and Keillor,<br/><span class="tab"></span> Jeffrey W.},<br/><span class="tab"></span> year={2023},<br/><span class="tab"></span> pages={277–298} }